Vyome Holdings, Embryyo Technologies sign MoU for AI-enabled medical devices

Vyome Holdings (HIND) and Embryyo Technologies announced the signing of an MoU to jointly pursue the global AI-enabled medical device market. This partnership will combine Vyome’s healthcare industry experience and resources with Embryyo’s medical technology capabilities. As part of this partnership, Vyome and Embryyo will host a global AI-enabled medical device innovation forum for companies along the US-India corridor. The MoU is non-binding and may be subject to other conditions.